miR-141-3p negatively regulates proliferation, migration and invasion and sensitizes CRC cells to cetuximab through suppression of EGFR, thus serving as a potential predictive biomarker for response to cetuximab [212]. This evidence concerns the gene EGFR and colorectal carcinoma.